Completed
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
NCT00640484
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Horizon Clinical Research Associates, PLLC Gilbert, Arizona, United States
- Pulmonary Associates, PA Phoenix, Arizona, United States
- UCLA David Geffen School of Medicine Los Angeles, California, United States
- University Clinical Research - DeLand, LLC DeLand, Florida, United States